BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 34853466)

  • 1. WTAP promotes proliferation of esophageal squamous cell carcinoma via m
    Zou J; Ma Q; Gao C; Yang M; Wen J; Xu L; Guo X; Zhong X; Duan Y
    Cancer Sci; 2024 May; ():. PubMed ID: 38746998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR-TKIs plus stereotactic body radiation therapy (SBRT) for stage IV Non-small cell lung cancer (NSCLC): A prospective, multicenter, randomized, controlled phase II study.
    Peng P; Gong J; Zhang Y; Zhou S; Li Y; Han G; Meng R; Chen Y; Yang M; Shen Q; Chu Q; Xia S; Zhang P; Zhang L; Chen Y; Zhang L
    Radiother Oncol; 2023 Jul; 184():109681. PubMed ID: 37105304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research Progress on the Predicting Factors and Coping Strategies for Postoperative Recurrence of Esophageal Cancer.
    Zhang Y; Zhang Y; Peng L; Zhang L
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical application of indocyanine green fluorescence imaging in laparoscopic lymph node dissection for intrahepatic cholangiocarcinoma: A pilot study (with video).
    Zhang Y; Zhang Y; Zhu J; Tao H; Liang H; Chen Y; Zhang Z; Zhao J; Zhang W
    Surgery; 2022 Jun; 171(6):1589-1595. PubMed ID: 34857382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GTF2E2 is a novel biomarker for recurrence after surgery and promotes progression of esophageal squamous cell carcinoma via miR-139-5p/GTF2E2/FUS axis.
    Zhang Y; Zhang Y; Ai B; Gong J; Li Y; Yu S; Cai X; Zhang L
    Oncogene; 2022 Feb; 41(6):782-796. PubMed ID: 34853466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GTF2E2 downregulated by miR-340-5p inhibits the malignant progression of glioblastoma.
    Qiao X; Chen Y; Wang Z; Peng N; Niu W; Hou S; Wu J; Ji Y; Niu C; Cheng C
    Cancer Gene Ther; 2023 Dec; 30(12):1702-1714. PubMed ID: 37845349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA XIST promotes the progression of esophageal squamous cell carcinoma through sponging miR-129-5p and upregulating CCND1 expression.
    Wang H; Li H; Yu Y; Jiang Q; Zhang R; Sun H; Xing W; Li Y
    Cell Cycle; 2021 Jan; 20(1):39-53. PubMed ID: 33345719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF2BP1/UHRF2 Axis Mediated by miR-98-5p to Promote the Proliferation of and Inhibit the Apoptosis of Esophageal Squamous Cell Carcinoma.
    Fang XY; Sun JJ; Chen SY; Wu KJ; Yu Y; Zhang C; Duan CZ
    Ann Clin Lab Sci; 2021 May; 51(3):329-338. PubMed ID: 34162562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
    Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
    IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
    Cheng J; Zhang R; Yan M; Li Y
    BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy.
    Tang S; Ou J; Liu J; Wu YP; Wu CQ; Chen TW; Zhang XM; Li R; Tang MJ; Yang LQ; Tan BG; Lu FL; Hu J
    Cancer Imaging; 2021 May; 21(1):38. PubMed ID: 34039403
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.